SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
75 hedge funds and large institutions have $641M invested in Sierra Oncology, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
Holders
75
Holding in Top 10
8
Calls
$4.1M
Puts
$644K
Top Buyers
| 1 | +$45.3M | |
| 2 | +$34.1M | |
| 3 | +$15.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15M |
| 5 |
Goldman Sachs
New York
|
+$14.1M |
Top Sellers
| 1 | -$38.8M | |
| 2 | -$13.2M | |
| 3 | -$11.3M | |
| 4 |
NLVP
New Leaf Venture Partners
New York
|
-$9.11M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.39M |